This is book # 3 in the Breathing Hearts series.  This book can be read as a standalone novel.  For reader enjoyment and to avoid spoilers, I recommend reading this series in order.

Frankie is just baking as usual when she feels tired and woozy.  Next thing she knows she is face to face with a blast from the past she did not want to see.  Rescuing her was nice, but coming back for more is just wrong.

Gage wants to move on from the past.  He comes back to his hometown with his daughter to start over.  Seeing Frankie puts him on alert.  Seeing her all the time gets his heart racing.  Can they get along long enough to work things out?

This story moved at such a quick pace.  The characters are strong with the heated backstory that sets the book on sizzle right from chapter one.  Sexy and smart, this was an enjoyable and relaxing read.  I give this a 4/5 Kitty's Paws UP!

***This early copy was given in exchange for an honest review only.

This is book #2 in the Breathing Hearts series.  This book can be read as a standalone novel.  To understand the series, and to avoid spoilers, I recommend reading this series in order.

Maddie got a first impression of the new neighbor.  Hint: It was not a good one. He was flat out rude. He was also hot as hell.  If she can get her mind of that magnificent tattooed bod, thinks may start looking up.

Adam misses his old life.  Moving to make a change, he left behind parents, career and everything that was familiar.  Now he has a neighbor with a dog who won't leave him alone.  Would be easier if he could ignore them both.

Between fighting the attraction and fighting one another, the sparks just literally continue to fly.  The heat is raring hot and the characters are intriguing.  I liked the pace and the story was a great read.  I give this a 4/5 Kitty's Paws UP!  

***This copy was given in exchange for an honest review.

Rae is talked into hooking up with the new local hottie.  Little does she know, when they finally exchange names there are several surprises!  What happens when she wants more?

Griffin was thrilled to find a welcoming woman, but he timing could have been better.  Once he finds out her brother works with him there is possible repercussions.  Should they take a chance on what they may have found?

While I found the pace quick, and the story rather fascinating, I was generally annoyed by the accent from Griffin being overly much.  I know the author was trying to set a tone, but it really turned me off.  The characters, however, are a joy to read and the fireworks were poppin'!  I give this book a 3/5 Kitty's Paws UP!

***This copy was given in exchange for an honest review only.

Breathing Disorders Treatment Market Overview

The breathing disorders treatment market is growing pervasively over the past few years. The market is getting a boost from the rising prevalence of various diseases & disorders related to respiratory tracts, such as COPD, asthma, allergic rhinitis, pulmonary hypertension, cystic fibrosis, IPF, and others. Moreover, increasing occurrences of lung diseases alongside the increasing geriatric population accelerates the market on a global level.

According to Market Research Future (MRFR), a leading research firm, the global breathing disorders treatment market may experience impressive growth by 2025. MRFR, in its recent study report, also asserts that the market would register a 7.5% CAGR during the review period (2019 – 2025). Augmenting demand for minimally invasive procedures for diagnosing & treatment supports the market growth.

Recent technological advancements are fostering market growth, offering phenomenally benefitting results, and improving the quality of life patients. Additionally, the increasing market demand led by the rising inclination of medical professionals is anticipated to boost the market growth, widening the adoption of drugs for treatments. Many emerging treatments and techniques are predicted to increase the size of the market.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/1575

Conversely, stringent government regulation related to steroid content, which leads to side effects and allergic reactions can hinder the market growth during the forecasted period. Also, unmet clinical needs in emerging regions are likely to pose challenges to the growth of the market. Nevertheless, growing advances in medical technology would support the market growth bringing about new techniques that can evolve treatments more effectively & efficiently.

Breathing Disorders Treatment Market - Segments

The report has been segmented into four dynamics to widen the scope of understanding,

By Drug Type: Antibiotics, Non-Steroidal Anti-Inflammatory Drug (NSAIDS), Cough Suppressant, Nasal Decongestant, and others.

By Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Rhinitis, Pulmonary Hypertension, Cystic Fibrosis (CF), Idiopathic Pulmonary Fibrosis, and others.

By End-user: Hospital & Clinics, Retail Pharmacies, Online Pharmacies, and others.

By Regions: Europe, North America, APAC, and the Rest-of-the-World (RoW).

Global Breathing Disorders Treatment Market - Regional Analysis

North America would continue dominating the global breathing disorders treatment market. The increasing prevalence of respiratory disorders and heart-related problems, alongside the rising geriatric population, drive the growth of the regional market. Breathing disorders treatment market in the US heads the regional market with the high occurrences of various pulmonary disorders and diseases.

Besides, the high prevalence of diseases such as cystic fibrosis in the US and Canada is expected to foster regional market growth. Furthermore, high healthcare expenditure and the high adoption of advanced technology drive the breathing disorders treatment market in North America.

Breathing disorders treatment market in the European region is expected to grow considerably over the forecast period. Factors such as the increasing health problems such as hypertension, stress, obesity, and changing lifestyles among the population drive the market demand hugely. Environmental changes are also contributing to regional market growth.

The presence of a well-established healthcare system and the involvement of key companies in the region are factors influencing the market. Additionally, increasing funding for research by private & public organizations would boost the growth of the breathing disorders market in this region.

The Asia Pacific breathing disorders treatment market is expected to register a substantial CAGR during the forecast period. The increasing patient population and government initiatives for healthcare reforms are driving the growth of the breathing disorders treatment market in the APAC region. Countries such as Japan, Hong Kong, and Singapore, significantly contribute to the regional market growth heading with the high prevalence of asthma. Also, the rising demand for pharmaceutical products required for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and other breathing-related disorders would support market growth.

Breathing Disorders Treatment Market - Competitive Analysis

Highly competitive, the global breathing disorders treatment market appears fragmented due to the presence of several well-established players. To gain a significant market share, players incorporate strategic initiatives like mergers & acquisitions, collaborations, expansion, and new therapeutics & technology launch. They invest heavily in R&D and clinical trials to develop effective drugs.

Major Players: 

Players leading the breathing disorders treatment market include AstraZeneca, GlaxoSmithKline, Merck Sharp & Dohme Corp., Abbott, Medtronic plc., Hoffmann-La Roche Ltd., Novartis AG, Reddy’s Laboratories, Amgen, Aurobindo Pharma, Bayer AG, and Biogen, among others. 

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/breathing-disorders-treatment-market-1575

Industry/Innovation/ Related News:

July 25, 2019 ---- Zambon S.p.A. (Italy), a multinational pharmaceutical company, announced the acquisition of Breath Therapeutics and its subsidiaries (Germany), a leading drug formulation and manufacturing company operating in Europe and the US. The acquisition would extend Zambon’s presence in severe respiratory diseases across Europe and the US.

It reinforces the company’s strategy to grow through further globalization and continued investment in Specialty Care. Breath Therapeutics is currently developing an innovative inhalation therapy for Bronchiolitis Obliterans Syndrome (BOS), a rare fatal respiratory disease. The therapeutics are in phase III.